Trial intelligence / Profile preview

Balanced Salt Solution vs Saline for Contrast Induced Nephropathy

NCT02799368Phase 3Completed

Sponsor
Seoul National University Hospital
Start
Nov 2016
Primary completion
May 2019
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of plasmalyte in contrast-induced acute kidney injury (CI-AKI), sponsored by Seoul National University Hospital. Started Nov 2016; status: completed.

02

Drugs

plasmalyte
03

Conditions

contrast-induced acute kidney injury (CI-AKI)

Beyond the preview

Go deeper on NCT02799368.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02799368.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call